Dáil Éireann Debate, Wednesday - 22 January 2025
1367. Deputy Duncan Smith asked the Minister for Health if his attention has been drawn to a drug shortage (details supplied); the steps that will be taken to address this shortage; and if he will make a statement on the matter. [46537/24]
View answerIn Ireland, we have a multi-stakeholder Medicines Shortages Framework in place, operated by our medicines regulator, the Health Products Regulatory Authority (HPRA) on behalf of the Department of Health. The framework aims to help prevent potential shortages from occurring and to reduce the impact of shortages on patients by coordinating the management of potential or actual shortages as they arise. Stakeholders in this framework include the HPRA, the Department, the HSE, healthcare professionals, manufacturers, wholesalers, patient representative groups and marketing authorisation holders.
The HPRA have not been notified of an ongoing shortage of Tyvense (lisdexamphetamine). A previous shortage of Tyvense 30mg Hard Capsules was resolved on 13th November 2024.
The HPRA maintains a list of current and resolved shortages on its website. The webpage is updated daily as the HPRA receives new information.
